Verastem Oncology Announces Positive Initial Interim Safety

Verastem Oncology announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine...

Related Keywords

Chicago , Illinois , United States , American , , Eastern Cooperative Oncology Group , American Society Of Clinical Oncology , Verastem Oncology , American Society , Clinical Oncology , Annual Meeting , Performance Status ,